44 reports

  • 2 Epidemiology
  • 8MM, Diagnosed Incident Cases of CRC (N), Ages ≥18 Years, Both Sexes, 2015 and 2025

PLoS One; ##(##): e##.

  • Colorectal Cancer
  • China
  • United States
  • Forecast
  • Cancer Epidemiology Group

Global Colorectal Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Colorectal Cancer
  • France
  • United States
  • World
  • Forecast

Prostate cancer epidemiology.

  • Colorectal Cancer
  • East Asia
  • North America
  • South America
  • Western Europe
  • Germany
  • Germany

PLoS one. 2011; ##(##):##-##. ##.

  • Colorectal Cancer
  • East Asia
  • North America
  • South America
  • Western Europe
  • REFERENCES

PLoS ONE. 2016; ##(##):##- ##. ##.

  • Colorectal Cancer
  • Italy
  • North America
  • South America
  • Southern Europe

Europe Colorectal Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Colorectal Cancer
  • Europe
  • France
  • Germany
  • Forecast

SUPPLIER POWER - Low ##.

  • Colorectal Cancer
  • North America
  • World
  • Market Size
  • Boston Scientific Corporation

TAKEDA PHARMACEUTICALS Chapter ## Appendix Acronyms List of Tables Summary Table : Global Colorectal Cancer Therapeutics Market, by Treatment Type, Through 2023 Table ## : U. S.

  • Colorectal Cancer
  • Therapy
  • World
  • Forecast
  • Market Size
  • Epidemiology
  • Epidemiology

EPIDEMIOLOGY PREV. ; ##(## SUPPL ##):##-##.

  • Colorectal Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • ABBREVIATIONS
  • Key events impacting the CRC marketplace are categorized into three subtypes.*

Claire Herman, MPH is Global Director of Therapy Analysis and Epidemiology at GlobalData in Boston.

  • Colorectal Cancer
  • China
  • United States
  • Array BioPharma Inc.
  • Eli Lilly & Co.
  • Five-year prevalen ce popu lation
  • CRC THERAPEUTICS MARKET, SOUTH KOREA, TREATMENT PATTERNS ('000), 2017-2024

Epidemiology and Health; ##(##): ##-## Yoshino T, et al. (2012).

  • Chemotherapy
  • Colorectal Cancer
  • Therapy
  • Market Size
  • Merck & Co., Inc.

Each of the covered ## country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes.

  • Colorectal Cancer
  • World
  • Forecast
  • Market Size
  • Supply

Colorectal Cancer Drugs/ Therapeutic Market Size, Share & Trends Analysis Report by Drug Class, By Country And Segment Forecasts, 2016 - 2022 Chapter ## Research Methodology ##. ## Information Procurement ##. ## Information or Data Analysis ##. ##. ## Market formulation & validation Chapte

  • Cancer
  • Colorectal Cancer
  • Pathology
  • United States
  • Forecast

Claire Herman, MPH is Global Director of Therapy Analysis and Epidemiology at GlobalData in Boston.

  • Colorectal Cancer
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Colorectal Cancer
  • France
  • United States
  • Market Shares
  • Market Size

## ## PRODUCT PROFILE (LATE STAGE): TECENTRIQ ## PRODUCT PROFILE: VECTIBIX ## PRODUCT PROFILE: ZALTRAP ## PRODUCT PROFILE (LATE STAGE): BINIMETINIB ## PRODUCT PROFILE (LATE STAGE): LEFITOLIMOD ## PRODUCT PROFILE (LATE STAGE): MASITINIB ## PRODUCT PROFILE (LATE STAGE): NAPABUCAS

  • Colorectal Cancer
  • European Union
  • Japan
  • United States
  • Demand

## PRODUCT PROFILE (LATE STAGE): TECENTRIQ PRODUCT PROFILE: VECTIBIX PRODUCT PROFILE: ZALTRAP PRODUCT PROFILE (LATE STAGE): BINIMETINIB PRODUCT PROFILE (LATE STAGE): LEFITOLIMOD PRODUCT PROFILE (LATE STAGE): MASITINIB PRODUCT PROFILE (LATE STAGE): NAPABUCASIN TREATMENT: COLORECTAL CANCER IN

  • Cancer
  • Colorectal Cancer
  • European Union
  • Japan
  • United States

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Colorectal Cancer
  • France
  • Germany
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • Japan
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • United States
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • United Kingdom
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • Italy
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • Germany
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • France
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • Spain
  • Market Shares
  • Market Size

The magnitude of the impact has been categorized as described below: Low Moderate - Medium-level impact on the market High - Negligible or no impact on the market landscape - Very high impact, with radical influence on the growth of the market ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Colorectal Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Merck Serono S.A.

Colorectal cancer

4385 5000 3900
  • Epidemiology: Colorectal Cancer in the US, Japan, and 5EU
  • PREVALENT CASES OF COLON CANCER IN THE US, JAPAN, AND FIVE MAJOR EU MARKETS, BY COUNTRY, 2013-33

PloS One, ##(##), e##.

  • Colorectal Cancer
  • European Union
  • Japan
  • North America
  • United States
  • EPIDEMIOLOGY

Incidence rates increased in China between 1991 and Source: Technavio, 2015 EPIDEMIOLOGY 2005.

  • Colorectal Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Sanofi S.A.
  • 5.2 References

Cancer Epidemiology, Biomarkers and Prevention; ##(##): ##-## Sikora K, et al. (1987).

  • Cancer
  • Colorectal Cancer
  • Pathology
  • Therapy
  • Roche Group

COLORECTAL CANCER DRUGS INDUSTRY AND MARKET: THERAPIES, R& D AND FORECASTS 2015-2025 Table of Contents ##.

  • Cancer
  • Colorectal Cancer
  • Pathology
  • World
  • Market Size